Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 27, 1990New England Journal of Medicine

Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia A

View Full Paper
Ask AI
Bookmark
Share

Authors

RSRichard S. SchwartzBrigham and Women's HospitalCACharles F. AbildgaardBaptist Memorial HospitalLALouis M. AledortIcahn School of Medicine at Mount Sinai

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Schwartz et al. (1990) studied this question.

synapsesocial.com/papers/6a7c8cd0fecf32cfa0610db3https://doi.org/10.1056/nejm199012273232604
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Characterization of recombinant factor VIII and a recombinant factor VIII deletion mutant using a rabbit immunogenicity model system1990 · 16 citations
  2. 2Efficacy of Self-Therapy in Hemophilia1974 · 80 citations